|
|
3698-C Haven Avenue
Redwood City, CA 94063 USA
phone:(650) 362-6000
fax:(650) 362-0070
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.baroSense.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Minimally invasive medical devices for the treatment of obesity. |
|
| Management |
| Richard S. Stack, M.D., Co-Founder and Chief Medical Officer, BaroSense, Inc.; William N. Starling, Chairman, BaroSense, Inc.; Daniel J. Balbierz, General Manager, BaroSense, Inc. |
| |
|
|
| |
|
| Keywords |
| minimally invasive, obesity, surgical treatment, diet |
|
|
|
| Description |
|
BaroSense Inc. focuses on the research and development of innovative, minimally invasive medical devices for the treatment of obesity - the largest global chronic disease in adults. |
|
| Technology / Differentiation |
| BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery. |
|
| Market / Customers |
Obesity has reached epidemic proportions in the US, affecting approximately 40 million US adults. It is estimated that more than 250 million people suffer from obesity worldwide.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members